Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | -3.85% | -11.79% | +112.80% |
12/06 | Geron Insider Sold Shares Worth $1,334,129, According to a Recent SEC Filing | MT |
10/06 | Barclays Initiates Geron at Overweight Rating With $9 Price Target | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
266.32Cr | - | |||||
12TCr | ||||||
11TCr | ||||||
2.27TCr | - | |||||
2.08TCr | - | |||||
1.67TCr |
- Stock Market
- Equities
- GERN Stock
- Charts Geron Corporation
- Sector Chart